Beijing Inno Medicine Co., Ltd.
Clinical trials sponsored by Beijing Inno Medicine Co., Ltd., explained in plain language.
-
New pill aims to tackle both heart trouble and erectile dysfunction
Disease control Not yet recruitingThis study tests an experimental drug called YN001 in 40 people who have both atherosclerotic cardiovascular disease (hardening of the arteries) and erectile dysfunction. The trial is double-blind and placebo-controlled, meaning neither patients nor doctors know who gets the real…
Phase: PHASE2 • Sponsor: Beijing Inno Medicine Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 06:51 UTC
-
New drug aims to shrink Heart-Artery plaque in major trial
Disease control Not yet recruitingThis study tests an experimental drug called YN001 in 456 adults with coronary atherosclerosis (plaque buildup in heart arteries). Participants will receive either YN001 or a placebo by IV, alongside their usual heart medications. The main goal is to see if YN001 reduces non-calc…
Phase: PHASE2 • Sponsor: Beijing Inno Medicine Co., Ltd. • Aim: Disease control
Last updated May 08, 2026 12:01 UTC
-
Healthy volunteers to test experimental heart drug combo
Knowledge-focused Not yet recruitingThis early-stage study tests whether a new drug called YN001 is safe when taken with a common cholesterol medicine (rosuvastatin). About 24 healthy Chinese adults will take both drugs and be monitored for side effects. The goal is to gather safety information, not to treat any di…
Phase: PHASE1 • Sponsor: Beijing Inno Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated May 26, 2026 06:49 UTC